A team of researchers’ published work in this month’s Royal Society journal Interface explain how seasonal H1N1 influenza became resistant to oseltamivir, otherwise known as Tamiflu, the most widely used antiviral agent for treating and preventing flu. The scientists say that a combination of genetic mutations and human migration through air travel can lead to the rapid spread of drug-resistant strains globally.
For more information, click here.
Source: University of Florida News
Sachiye Day, VERTICES intern. email@example.com